Penetrances of BRCA1 1675delA and 1135insA with Respect to Breast Cancer and Ovarian Cancer
- 1 September 1999
- journal article
- research article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 65 (3) , 671-679
- https://doi.org/10.1086/302530
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer PatientsAmerican Journal of Human Genetics, 1998
- Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancerThe Breast, 1998
- Is hereditary site-specific ovarian cancer a distinct genetic condition?American Journal of Medical Genetics, 1998
- A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingEuropean Journal Of Cancer, 1997
- Evidence That Adult Life Risk Factors Influence the Expression of Familial Propensity to Breast CancerEpidemiology, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.1997
- A common BRCA1 mutation in Norwegian breast and ovarian cancer families?1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.1995